Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Dasatinib × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Burkitt Lymphoma 4 Multiple Myeloma 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Philadelphia Chromosome 2 Pancreatic Neoplasms 2 Neoplasms 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Hematologic Neoplasms 2 Glioma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Prostate Cancer Recurrent 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1

Interventions

X-Rays 4 Specimen Handling 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Nuclear Medicine Department, Hospital 3 Biopsy 3 ulixertinib 2 tazemetostat 2 palbociclib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 LY3023414 2 tipifarnib 1 temsirolimus 1 talazoparib 1 selpercatinib 1 olaparib 1 larotrectinib 1 irinotecan sucrosofate 1 Vincristine 1 Vemurafenib 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiation 1 Proton Therapy 1 Pharmacogenomic Variants 1 Liquid Biopsy 1 Ifosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡